Search research articles
Contact Us
Filters
Showing results (61-70 of 98) with videos related to
Page
of 10
Sort By:
Transplantation and Cellular Therapy
|
July 5, 2026
System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced Cost
Shernan G Holtan, Megan M Herr, Kanwal Mallhi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 9, 2019
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma
Austin J Sim, Michael D Jain, Nicholas B Figura, et al.
Gastrointestinal Endoscopy
|
February 10, 2016
Outcome of EMR as an alternative to surgery in patients with complex colon polyps
Gottumukkala S Raju, Phillip J Lum, William A Ross, et al.
Frontiers in Immunology
|
June 6, 2018
VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and Rearrangements
Scott Christley, Walter Scarborough, Eddie Salinas, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma
Abu-Sayeef Mirza, Ambuj Kumar, Hamza Hashmi, et al.
Blood Advances
|
July 24, 2020
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
Erin A Dean, Rahul S Mhaskar, Hong Lu, et al.
The Journal of Clinical Investigation
|
October 30, 2025
IFN-γ-driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapy
Payal Goala, Yongliang Zhang, Nolan Beatty, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
The Lancet. Haematology
|
February 10, 2023
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
David A Sallman, Tessa Kerre, Violaine Havelange, et al.
Molecular Therapy. Methods & Clinical Development
|
September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience
Kenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 98) with videos related to
Sort By:
Page
of 10
Transplantation and Cellular Therapy
|
July 5, 2026
System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced Cost
Shernan G Holtan, Megan M Herr, Kanwal Mallhi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 9, 2019
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma
Austin J Sim, Michael D Jain, Nicholas B Figura, et al.
Gastrointestinal Endoscopy
|
February 10, 2016
Outcome of EMR as an alternative to surgery in patients with complex colon polyps
Gottumukkala S Raju, Phillip J Lum, William A Ross, et al.
Frontiers in Immunology
|
June 6, 2018
VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and Rearrangements
Scott Christley, Walter Scarborough, Eddie Salinas, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma
Abu-Sayeef Mirza, Ambuj Kumar, Hamza Hashmi, et al.
Blood Advances
|
July 24, 2020
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
Erin A Dean, Rahul S Mhaskar, Hong Lu, et al.
The Journal of Clinical Investigation
|
October 30, 2025
IFN-γ-driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapy
Payal Goala, Yongliang Zhang, Nolan Beatty, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
The Lancet. Haematology
|
February 10, 2023
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
David A Sallman, Tessa Kerre, Violaine Havelange, et al.
Molecular Therapy. Methods & Clinical Development
|
September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience
Kenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Page
of 10